Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 2-Week Double-Blind, Placebo-Controlled, Parallel Group Study Comparing the Anti-Inflammatory Effects of Low, Medium, and High Dose Mometasone Furoate/Formoterol Fumarate MDI Formulation and Medium Dose Mometasone Furoate DPI and MDI Formulations in Adults and Adolescents With Persistent Allergic Asthma

NCT00635882 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT00635882
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00635882 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 2-Week Double-Blind, Placebo-Controlled, Parallel Group Study Comparing the Anti-Inflammatory Effects of Low, Medium, and High Dose Mometasone Furoate/Formoterol Fumarate MDI Formulation and Medium Dose Mometasone Furoate DPI and MDI Formulations in Adults and Adolescents With Persistent Allergic Asthma
Lead sponsor
Organon and Co
Phase
Phase 2
Overall status
Completed
Start date
February 29, 2008
Completion date
June 30, 2009
Enrollment
93 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

airway inflammation, asthma